Voyager Therapeutics, Inc. (VYGR)
3.51
+0.08
(+2.33%)
USD |
NASDAQ |
Sep 02, 15:02
Voyager Therapeutics Total Assets (Quarterly) : 197.75M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 197.75M |
| March 31, 2026 | 219.32M |
| December 31, 2025 | 252.28M |
| September 30, 2025 | 288.31M |
| June 30, 2025 | 322.10M |
| March 31, 2025 | 353.24M |
| December 31, 2024 | 393.05M |
| September 30, 2024 | 426.04M |
| June 30, 2024 | 436.22M |
| March 31, 2024 | 469.59M |
| December 31, 2023 | 351.28M |
| September 30, 2023 | 294.65M |
| June 30, 2023 | 315.54M |
| March 31, 2023 | 336.29M |
| December 31, 2022 | 159.36M |
| September 30, 2022 | 182.48M |
| June 30, 2022 | 188.60M |
| March 31, 2022 | 224.18M |
| December 31, 2021 | 193.86M |
| September 30, 2021 | 184.77M |
| June 30, 2021 | 208.73M |
| March 31, 2021 | 237.72M |
| December 31, 2020 | 261.58M |
| Date | Value |
|---|---|
| September 30, 2020 | 269.76M |
| June 30, 2020 | 297.46M |
| March 31, 2020 | 322.61M |
| December 31, 2019 | 354.76M |
| September 30, 2019 | 376.22M |
| June 30, 2019 | 388.59M |
| March 31, 2019 | 411.35M |
| December 31, 2018 | 177.03M |
| September 30, 2018 | 197.06M |
| June 30, 2018 | 214.66M |
| March 31, 2018 | 235.03M |
| December 31, 2017 | 184.48M |
| September 30, 2017 | 140.92M |
| June 30, 2017 | 158.41M |
| March 31, 2017 | 175.09M |
| December 31, 2016 | 189.57M |
| September 30, 2016 | 201.98M |
| June 30, 2016 | 209.82M |
| March 31, 2016 | 219.98M |
| December 31, 2015 | 229.46M |
| September 30, 2015 | 166.44M |
| June 30, 2015 | 173.76M |
| March 31, 2015 | 120.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 43.38M |
| Shareholders Equity (Quarterly) | 154.38M |
| Debt to Equity Ratio | 0.211 |
| Current Ratio | 7.505 |
| Net Debt Paydown Yield | 0.88% |